# Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China

> **NCT01933776** · PHASE1 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 40 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Pertussis

## Interventions

- **BIOLOGICAL:** Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap
- **BIOLOGICAL:** Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap

## Key facts

- **NCT ID:** NCT01933776
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-11
- **Final completion:** 2014-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933776, "Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01933776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*